A study to see the effect of drug(Akaarakarabha churna)in a condition of passing Dhat during urination.

A Randomized Double blind clinical trial to evaluate the efficacy of Akaarakarabha mool choorna in Dhat syndrome (shukra pradoshaja vikaar)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019760

Enrollment

Registered

2019-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N539- Unspecified male sexual dysfunction

Interventions

Intervention1: Akarakarbha mool churna: 1 gm capsule twice a day,orally after meal with normal water Control Intervention1: Placebo: 1 gm capsule twice a day,orally after meal with normal water

Eligibility

Inclusion criteria

Inclusion criteria: Male patients of 14 to 45 years of age complaining of passing semen with urine

Exclusion criteria

Exclusion criteria: Other systemic diseases of GIT

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of Dhat syndrome (shukra pradoshaj vikaar).Timepoint: 1 month	—

Secondary

Measure	Time frame
1.Improvisation in the education status of the individual regarding Dhat syndrome (shukra pradoshaj vikaar) 2.Understanding and arriving at the nearest correlation of Dhat syndrome in Ayurveda. Timepoint: 1 month	—

Countries

India

Contacts

Public ContactAbhay kumar prajapati

All India Institute of Ayurveda

drvghuddar@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026